Association between CYP17 gene polymorphism and risk of breast cancer in young women

International Journal of Cancer

Volumn 84, Issue 4, 1999, Pages 350-353

  Bergman Jungestrom, Malin ^a   Gentile, Massimiliano ^a   Lundin, Anna Carin ^a   Wingren, Sten ^a   Nordenskjold B ^b   Arnesson, L G ^b   Malmstrom A ^b   Bang H ^b   Einarsson, E ^b   Kallstrom A C ^b   Norberg, B ^b   Henning, Å ^b   Sundqvist, M ^b   Adlouni, W ^b   Tejler, G ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE SEQUENCE; GENOTYPE; HORMONE SYNTHESIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS;

ADULT; AGE FACTORS; ALLELES; BASE SEQUENCE; BREAST NEOPLASMS; CELL CYCLE; CONFIDENCE INTERVALS; FEMALE; HETEROZYGOTE DETECTION; HUMANS; LYMPHATIC METASTASIS; ODDS RATIO; POINT MUTATION; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE; SURVIVAL ANALYSIS; SWEDEN;

EID: 0032773048     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990820)84:4<350::AID-IJC3>3.0.CO;2-L     Document Type: Article

References (23)

1. AMBROSONE, B.C., FREUDENHEIM, J.L., GRAHAM, S., MARSHALL, J.R., VENA, J.E., BRASURE, J.R., LAUGHLIN, R., NEMOTO, T., MICHALEK, A.M., HARRINGTON, A., FORD, T.D. and SHIELDS, P.G., Cytochrome P4501A1 and glutathione s-transferase (MI) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res., 55, 3483-3485 (1995).
2. BERNSTEIN, L. and PRESS, M.F., Does estrogen receptor expression in normal breast tissue predict breast cancer risk? J. nat. Cancer Inst., 90, 5-7 (1998).
3. BONNIER, P., ROMAIN, S., CHARPIN, C., LEJEUNE, C., TUBIANA, N., MARTIN, PM. and PIANA, L., Age as a prognostic factor in breast cancer: relationship to pathology and biological features. Int. J. Cancer, 62, 138-144 (1995).
4. BRENTANO, S.T., PICADO-LEONARD, J., MELLON, S.H., MOORE, C.C.D. and MILLER, W.L., Tissue-specific, cyclic adenosine 3′,5′-monophosphate-induced, and phorbol ester-repressed transcription from the human P450c 17 promoter in mouse cells. Mol. Endocrinol., 4, 1972-1979 (1990).
5. CAREY, A.H., WATERWORTH, D., PATEL, K., WHITE, D., LITTLE, J., NOVELLI, P., FRANKS, S. and WILLIAMSON, R., Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum. mol. Genetics, 3, 1873-1876 (1994).
6. CASEY, G., The BRCA1 and BRCA2 breast cancer genes. Curr. Opin. Oncol., 9, 88-93 (1997).
7. CLARKE, R.B., HOWELL, A., POTTEN, C.S. and ANDERSON, E., Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res., 57, 4987-4991 (1997).
8. DUNNING, A.M., HEALEY, C.S., PHAROAH, P.D.P., FOSTER, N.A., LIPSCOMBE, J.M., REDMAN, K.L., EASTON, D.F., DAY, N.E. and PONDER, B.A.J., No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. Brit. J. Cancer, 77, 2045-2047 (1998).
9. FEIGELSON, H.S., COETZEE, G.A., KOLONEL, L.N., ROSS, R.K. and HENDERSON, B.E., A polymorphism in the CYP 17 gene increases the risk of breast cancer. Cancer Res., 57, 1063-1065 (1997).
10. FEIGELSON, H.S., ROSS, R.K., YU, M.C., COETZEE, G.A., REICHARDT, J.K.V. and HENDERSON, B.E., Genetic susceptibility to cancer from exogenous and endogenous exposures. J. Cell Biochem., 25, 15-22 (1996).
11. FEIGELSON, H.S., SHAMES, L.S., PIKE, M.C., COETZEE, G.A., STANCZYK, F.Z. and HENDERSON, B.E., Cytochrome P450c17α gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res., 58, 585-587 (1998).
12. HALL, J.M., FRIEDMAN, L., GUENTHER, C., LEE, M.K., WEBER, J.L., BLACK, D.M. and KINO, M-C., Closing in on a breast cancer gene on chromosome 17q. Amer. J. hum. Genet. 50, 1235-1242 (1992).
13. HELZLSOUER, K.J., HUANG, H-Y., STRICKLAND, P.T., HOFFMAN, S., ALBERG, A.J., COMSTOCK, G.W. and BELL, D.A., Association between CYP17 polymorphism and the development of breast cancer. Cancer Epidemiol. Biomarkers Prev. 7, 945-949 (1998).
14. KADONAGA, J.T., JONES, K.A. and TJIAN, R., Promoter-specific activation of RNA polymeras II transcription by Sp1. Trends biochem. Sci., 11, 20-23 (1986).
15. LAVIGNE, J.A., HELZLSOUER, K.J., HUANG, H.Y., STRICKLAND, P.T., BELL, D.A., SELMIN, O., WATSON, M.A., HOFFMAN, S., COMSTOCK, G.W. and YAGER, J.D., An association between the allele coding for a low variant of catechol-o-methyltransferase and the risk for breast cancer. Cancer Res., 57, 5493-5497 (1997).
16. NIXON, A.J., NEUBERG, D., HAYES, D.F., GELMAN, R., CONNOLLY, J.L., SCHNITT, S., ABNER, A., RECHT, A., VICINI, F. and HARRIS, J.R., Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J. clin. Oncol., 12, 888-894 (1994).
17. PICADO-LEONARD, J. and MILLER, W.L., Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17,20 lyase): similarity with the gene for P450c21. DNA, 6, 439-448 (1987).
18. SHIBATA, D., BRYNES, R.K., NATHWANI, B., KWOK, S., SNINSKY, J. and ARNHEIM, N., Human immunodeficiency viral DNA is readily found in lymph node biopsies from seropositive individuals. Analysis of fixed tissue using the polymerase chain reaction. Amer. J. Pathol., 135, 697-702 (1989).
19. TAIOLI, E., TRACHMAN, J., CHEN, X., TONIOLO, P. and GARTE, S.J., A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res., 55, 3757-3758 (1995).
20. THOMPSON, P.A., SHIELDS, P.G., FREUDENHEIM, J.L., STONE, A., VENA, J.E., MARSHALL, J.R., GRAHAM, S., LAUGHLIN, R., NEMOTO, T., KADLUBAR, F.F. and AMBROSONE, C.B., Genetic polymorphism in catechol-o-metyltransferase, menopausal status and breast cancer risk. Cancer Res., 58, 2107-2110 (1998).
21. WESTON, A., PAN, C-F., BLEIWEISS, I.J., KSIESKI, H.B., ROY, N., MALONEY, N. and WOLFF, M.S., CYP17 Genotype and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 7, 941-944 (1998).
22. WOOSTER, R. and 26 others, Localisation of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science, 265, 2088-2090 (1994).
23. ZHONG, S., WYLLIE, A.H., BARNES, D., WOLF, C.R. and SPURR, N.K., Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis, 14, 1821-1824 (1993).